Partex

Company Deals

Shanghai Ark Bio and Partex Collaborate on ATR Inhibitor AK0658 Development

Fineline Cube Jun 3, 2025

China’s Shanghai Ark Biopharmaceutical Co., Ltd. has entered into a new cooperation agreement with Germany-based...

Company Deals

Shanghai Ark Biopharmaceutical Partners with Partex to Advance AI-Driven Drug Development

Fineline Cube Dec 30, 2024

China’s Shanghai Ark Biopharmaceutical Co., Ltd. has formed a strategic alliance with Germany-based Partex, an...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod